It wasn’t the ongoing opioid overdose crisis that inspired Kim Janda to start developing a heroin vaccine. America’s latest drug problem hadn’t even really set in when the Scripps Research Institute chemist went to work in his lab. But developing countries were witnessing an HIV spike, driven in part by intravenous drug use, and Janda wanted to find a way to fight it.
So he set to work on a vaccine, a treatment that could make the body fight off heroin molecules almost the way it would fight off a virus.
Something like Janda’s vaccine could offer a new hope – but it’s a completely different approach to drug treatment. With clinical trials inching the treatment closer to possible market availability, Janda offered some insights as to how the treatment could work in a January interview with the Chronicle.”
Source: Chron.com – January 25, 2018